infusystem holdings inc - INFU

INFU

Close Chg Chg %
11.94 0.07 0.59%

Open Market

12.01

+0.07 (0.59%)

Volume: 43.20K

Last Updated:

Sep 9, 2026, 10:52 AM EDT

Company Overview: infusystem holdings inc - INFU

INFU Key Data

Open

$11.91

Day Range

11.91 - 12.07

52 Week Range

7.29 - 12.93

Market Cap

$243.79M

Shares Outstanding

19.92M

Public Float

18.82M

Beta

1.50

Rev. Per Employee

N/A

P/E Ratio

30.03

EPS

$0.42

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

101.53K

 

INFU Performance

1 Week
 
-2.86%
 
1 Month
 
-4.80%
 
3 Months
 
30.09%
 
1 Year
 
19.02%
 
5 Years
 
-13.34%
 

INFU Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 3
Full Ratings ➔

About infusystem holdings inc - INFU

InfuSystem Holdings, Inc. engages in the provision of healthcare services. It operates through the Patient Services and Device Solutions segments. The Patient Services segment involves the durable medical equipment, clinic-to-home health care, logistics and billing, and oncology business. The Device Solutions segment includes the sale or rent of new and pre-owned pole-mounted and ambulatory infusion pumps, treatment-related consumables, biomedical recertification, maintenance and repair services for oncology practices. The company was founded by Steven E. Watkins in August 2005 and headquartered in Rochester Hills, MI.

INFU At a Glance

InfuSystem Holdings, Inc.
3851 West Hamlin Road
Rochester Hills, Michigan 48309
Phone 1-248-291-1210 Revenue 143.44M
Industry Miscellaneous Commercial Services Net Income 6.63M
Sector Commercial Services 2025 Sales Growth 6.358%
Fiscal Year-end 12 / 2026 Employees 473
View SEC Filings

INFU Valuation

P/E Current 30.029
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 28.558
Price to Sales Ratio 1.319
Price to Book Ratio 3.162
Price to Cash Flow Ratio 7.75
Enterprise Value to EBITDA 8.348
Enterprise Value to Sales 1.468
Total Debt to Enterprise Value 0.116

INFU Efficiency

Revenue/Employee 303,247.357
Income Per Employee 14,010.571
Receivables Turnover 6.263
Total Asset Turnover 1.304

INFU Liquidity

Current Ratio 1.80
Quick Ratio 1.533
Cash Ratio 0.158

INFU Profitability

Gross Margin 54.502
Operating Margin 8.31
Pretax Margin 7.406
Net Margin 4.62
Return on Assets 6.026
Return on Equity 11.54
Return on Total Capital 8.105
Return on Invested Capital 7.968

INFU Capital Structure

Total Debt to Total Equity 42.633
Total Debt to Total Capital 29.89
Total Debt to Total Assets 22.41
Long-Term Debt to Equity 40.212
Long-Term Debt to Total Capital 28.193
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Infusystem Holdings Inc - INFU

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
109.91M 125.78M 134.86M 143.44M
Sales Growth
+7.36% +14.44% +7.22% +6.36%
Cost of Goods Sold (COGS) incl D&A
50.94M 64.77M 66.75M 65.26M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
13.36M 12.51M 12.50M 13.29M
Depreciation
10.87M 11.52M 11.51M 12.37M
Amortization of Intangibles
2.49M 990.00K 991.00K 920.00K
COGS Growth
+7.58% +27.15% +3.06% -2.23%
Gross Income
58.98M 61.02M 68.11M 78.18M
Gross Income Growth
+7.16% +3.46% +11.62% +14.78%
Gross Profit Margin
+53.66% +48.51% +50.51% +54.50%
2022 2023 2024 2025 5-year trend
SG&A Expense
57.32M 56.93M 61.22M 66.26M
Research & Development
- - - -
-
Other SG&A
57.32M 56.93M 61.22M 66.26M
SGA Growth
+10.20% -0.68% +7.54% +8.22%
Other Operating Expense
- - - -
-
Unusual Expense
- - - -
-
EBIT after Unusual Expense
1.65M 4.09M 6.89M 11.92M
Non Operating Income/Expense
76.00K 670.00K 639.00K 508.00K
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
1.60M 2.91M 2.47M 1.80M
Interest Expense Growth
+25.89% +81.69% -15.00% -26.95%
Gross Interest Expense
1.60M 2.91M 2.47M 1.80M
Interest Capitalized
- - - -
-
Pretax Income
130.00K 1.85M 5.06M 10.62M
Pretax Income Growth
-89.66% +1,323.85% +173.31% +109.98%
Pretax Margin
+0.12% +1.47% +3.75% +7.41%
Income Tax
112.00K 979.00K 2.71M 4.00M
Income Tax - Current - Domestic
99.00K 245.00K 488.00K 755.00K
Income Tax - Current - Foreign
(8.00K) 101.00K 308.00K 513.00K
Income Tax - Deferred - Domestic
21.00K 633.00K 1.92M 2.73M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
18.00K 872.00K 2.35M 6.63M
Minority Interest Expense
- - - -
-
Net Income
18.00K 872.00K 2.35M 6.63M
Net Income Growth
-98.73% +4,744.44% +168.92% +182.60%
Net Margin Growth
+0.02% +0.69% +1.74% +4.62%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
18.00K 872.00K 2.35M 6.63M
Preferred Dividends
- - - -
-
Net Income Available to Common
18.00K 872.00K 2.35M 6.63M
EPS (Basic)
0.0009 0.0415 0.1102 0.3208
EPS (Basic) Growth
-98.70% +4,511.11% +165.54% +191.11%
Basic Shares Outstanding
20.65M 21.02M 21.27M 20.66M
EPS (Diluted)
0.0008 0.0403 0.108 0.3141
EPS (Diluted) Growth
-98.76% +4,937.50% +167.99% +190.83%
Diluted Shares Outstanding
21.55M 21.65M 21.71M 21.10M
EBITDA
15.01M 16.60M 19.39M 25.21M
EBITDA Growth
-14.91% +10.54% +16.84% +30.04%
EBITDA Margin
+13.66% +13.19% +14.38% +17.58%

Snapshot

Average Recommendation BUY Average Target Price 17.625
Number of Ratings 3 Current Quarters Estimate 0.13
FY Report Date 09 / 2026 Current Year's Estimate 0.46
Last Quarter’s Earnings 0.15 Median PE on CY Estimate N/A
Year Ago Earnings 0.31 Next Fiscal Year Estimate 0.567
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 3 3
Mean Estimate 0.13 0.13 0.46 0.57
High Estimates 0.15 0.14 0.48 0.60
Low Estimate 0.12 0.13 0.44 0.52
Coefficient of Variance 13.32 4.33 4.35 7.35

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 3 3 4
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Infusystem Holdings Inc in the News